Medications in Patients Treated With Therapeutic Plasma Exchange: Prescription Dosage, Timing, and Drug Overdose

Seminars in Dialysis

Volumn 25, Issue 2, 2012, Pages 176-189

  Ibrahim, Rami B ^a,c   Balogun, Rasheed A ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; PRESCRIPTION DRUG;

ARTICLE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; FOLLOW UP; HUMAN; INTOXICATION; MALE; METHODOLOGY; MORTALITY; PLASMAPHERESIS; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OVERDOSE; PHARMACEUTICAL PREPARATIONS; PLASMA EXCHANGE; PLASMAPHERESIS; PRESCRIPTION DRUGS; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84858708346     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2011.01030.x     Document Type: Article

References (133)

1. Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A: Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 76:294-300, 2011
2. Kale-Pradhan PB, Woo MH: A review of the effects of plasmapheresis on drug clearance. Pharmacotherapy 17:684-695, 1997
3. Okafor C, Ward DM, Mokrzycki MH, Weinstein R, Clark P, Balogun RA: Introduction and overview of therapeutic apheresis. J Clin Apher 25:240-249, 2010
4. El-Ghariani K, Unsworth DJ: Therapeutic apheresis-plasmapheresis. Clin Med 6:343-347, 2006
5. Balogun RA, Ogunniyi A, Sanford K, Okafor C, Lobo PI, Siami G, Barcia J, Kaplan AA: Therapeutic apheresis in special populations. J Clin Apher 25:265-274, 2010
6. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH, Apheresis Applications Committee of the American Society for Apheresis: Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apheresis 25:83-177, 2010
7. Balogun RA, Kaplan A, Ward DM, Oakfor C, Burns TM, Torloni AS, Macik BG, Abdel-Rahman EM: Clinical applications of therapeutic apheresis. J Clin Apheresis 25:250-264, 2010
8. Stigelman Jr WH, Henry DH, Talbert RL, Townsend RJ: Removal of prednisone and prednisolone by plasma exchange. Clin Pharm 3:402-407, 1984
9. Shelat SG: Practical considerations for planning a therapeutic apheresis procedure. Am J Med 123:777-784, 2010
10. Ibrahim RB, Liu C, Cronin SM, Murphy BC, Cha R, Swerdlow P, Edwards DJ: Drug removal by plasmapheresis: an evidence-based review. Pharmacotherapy 27:1529-1549, 2007
11. Keller F, Wagner K, Faber U, Scholle J, Neumayer HH, Maiga M, Schultze G, Offermann G, Molzahn M: Elimination kinetics of plasma exchange. Klin Wochenschr 61:1115-1122, 1983
12. Sketris I, WA P, JV J: Plasmapheresis: its effect on toxic agents and drugs. Plasma Ther Transfus Technol 5:305-317, 1984
13. Ibrahim RB, Liu CY, Cronin SM, Murphy Bc, Cha R, Swerdlow P, Avila T, Smith ST, Lewis RA, Edwards DJ: Influence of plasma exchange on the disposition of the fourth generation cephalosporin cefepime. J Oncol Pharm Pract 15:217-222, 2009
14. Brown-Molnar CS, Bauer LA, Horn JR: Phenytoin removal by plasmapheresis in renal insufficiency. Am J Nephrol 6:302-306, 1986
15. Ezidiegwu C, Spektor Z, Nasr MR, Kelly KC, Rosales LG: A case report on the role of plasma exchange in the management of a massive amlodipine besylate intoxication. Ther Apher Dial 12:180-184, 2008
16. Nenov VD, Marinov P, Sabeva J, Nenov DS: Current applications of plasmapheresis in clinical toxicology. Nephrol Dial Transplant 18(Suppl. 5):v56-v58, 2003
17. Putz G, Schmah O, Eckes J, Hug MJ, Winkler K: Controlled application and removal of liposomal therapeutics: effective elimination of pegylated liposomal doxorubicin by double- filtration plasmapheresis in vitro. J Clin Apheresis 25:54-62, 2010
18. Sebe A, Satar S, Rana Alpay N, Murt M, Guvenc B: Severe acetaminophen poisoning treated with a fractionated plasma separation and absorption system: a case report. Hum Exp Toxicol 28:729-732, 2009
19. Alet P, Lortholary O, Fauvelle F, Tod M, Genereau T, Louchahi M, Leon A, Guillevin L, Petitjean O: Pharmacokinetics of teicoplanin during plasma exchange. Clin Microbiol Infect 5:213-218, 1999
20. Fauvelle F, Lortholary O, Tod M, Guillevin L, Louchahi M, Leon A, Petitjean O: Pharmacokinetics of ceftriaxone during plasma exchange in polyarteritis nodosa patients. Antimicrob Agents Chemother 38:1519-1522, 1994
21. Bozkurt F, Schollmeyer P, Keller E: Kinetics of ceftazidime during plasmapheresis. Eur J Clin Pharmacol 33:197-201, 1987
22. Sagraves R, Bradberry JC: The effects of exchange transfusion on the pharmacokinetics of phenobarbital. Drug Intell Clin Pharm 17:901-903, 1983
23. McClellan SD, Whitaker CH, Friedberg RC: Removal of vancomycin during plasmapheresis. Ann Pharmacother 31:1132-1136, 1997
24. Kliegman RM, Bertino Jr JS, Fanaroff AA, Gavan TL, Speck WT: Pharmacokinetics of gentamicin during exchange transfusions in neonates. J Pediatr 96:927-930, 1980
25. Bertino Jr JS, Kliegman RM, Myers CM, Blumer JL: Alterations in gentamicin pharmacokinetics during neonatal exchange transfusion. Dev Pharmacol Ther 4:205-215, 1982
26. Binimelis J, Bassas L, Marruecos L, Rodriguez J, Domingo ML, Madoz P, Armengol S, Mangues MA, de Leiva A: Massive thyroxine intoxication: evaluation of plasma extraction. Intensive Care Med 13:33-38, 1987
27. White RL, Garnett WR, Poynor WJ, Allen JH, Sharp DE: Salicylate removal during plasma exchange in normal volunteers. Clin Pharm 3:396-402, 1984
28. Keller F, Hauff A, Schultze G, Offermann G, Reeck S, Molzahn M, Kreutz G, Vohringer F: Effect of repeated plasma exchange on steady state kinetics of digoxin and digitoxin. Arzneimittelforschung 34:83-86, 1984
29. Keller F, Kreutz G, Vohringer HF, Offermann G, Distler A: Effect of plasma exchange on the steady-state kinetics of digoxin and digitoxin. Clin Pharmacokinet 10:514-523, 1985
30. Kintzel PE, Eastlund T, Calis KA: Extracorporeal removal of antimicrobials during plasmapheresis. J Clin Apheresis 18:194-205, 2003
31. Kolcz J, Pietrzyk J, Januszewska K, Procelewska M, Mroczek T, Malec E: Extracorporeal life support in severe propranolol and verapamil intoxication. J Intensive Care Med 22:381-385, 2007
32. Darabi K, Berg AH: Rituximab can be combined with daily plasma exchange to achieve effective B-cell depletion and clinical improvement in acute autoimmune TTP. Am J Clin Pathol 125:592-597, 2006
33. McDonald VSM, Mackie I, Manns K, Machin S: The effect of plasma exchange on rituximab levels and response to rituximab in patients with acute idiopathic thrombotic thrombocytopenic purpura. 50th ASH Annual Meeting and Exposition, San Francisco, December 6-9, 2008, 2297 Abstract Number (Abstract).
34. Khatri BO, Man S, Giovannoni G, Koo AP, Lee JC, Tucky B, Lynn F, Jurgensen S, Woodworth J, Goelz S, Duda PW, Panzara MA, Ransohoff RM, Fox RJ: Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function. Neurology 72:402-409, 2009
35. Carson KR, Focosi D, Major EO, Petrini M, Richey EA, West DP, Bennett CL: Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol 10:816-824, 2009
36. Russell DC, Paton L, Douglas AC: Amiodarone associated alveolitis and polyarthropathy. Treatment by plasma exchange. Br Heart J 50:491-494, 1983
37. Uzzan B, Pussard E, Leon A, Bekhechi D, Krivitzky A, Modigliani E, Perret G, Vassy R, Berdeaux A, Giudicelli JF: The effects of plasmapheresis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis. Br J Clin Pharmacol 31:371-372, 1991
38. Diamond TH, Rajagopal R, Ganda K, Manoharan A, Luk A: Plasmapheresis as a potential treatment option for amiodarone-induced thyrotoxicosis. Intern Med J 34:369-370, 2004, author reply 70-71
39. Aghini-Lombardi F, Mariotti S, Fosella PV, Grasso L, Pinchera A, Braverman LE, Martino : Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole. J Endocrinol Invest 16:823-826, 1993
40. Hastings D, Patel B, Torloni AS, Mookadam F, Betcher J, Moss A, Heilman R, Mazur M, Hamawi K, Mulligan D, Reddy K, Mekeel K, Chakkera H: Plasmapheresis therapy for rare but potentially fatal reaction to rituximab. J Clin Apheresis 24:28-31, 2009
41. Zdunek M, Mitra A, Mokrzycki MH: Plasma exchange for the removal of digoxin-specific antibody fragments in renal failure: timing is important for maximizing clearance. Am J Kidney Dis: the official journal of the National Kidney Foundation 36:177-183, 2000
42. Choi JH, Oh JC, Kim KH, Chong SY, Kang MS, Oh DY: Successful treatment of cisplatin overdose with plasma exchange. Yonsei Med J 43:128-132, 2002
43. Tiftik N, Kiykim A, Altintas E, Sezer K, Doruk N, Sezgin O, Seyrek E, Buyukafsar K, Oral U: Therapeutic plasma exchange for multidrug intoxication: a case report. J Clin Apheresis 18:132-133, 2003
44. Sabloff M, Wells PS: The effect of plasmapheresis on the serum activity level of dalteparin: a case report. Blood Coagul Fibrinolysis 11:395-400, 2000
45. Fauvelle F, Nicolas P, Leon A, Tod M, Perrett G, Petitjean O, Guillevin L: Diclofenac, paracetamol, and vidarabine removal during plasma exchange in polyarteritis nodosa patients. Biopharm Drug Dispos 12:411-424, 1991
46. Martin SG, Kearns GL, Brod M, Austin G, Vaughan BC: Impact of plasmapheresis on disopyramide elimination. Pediatr Nephrol 13:323-325, 1999
47. Prince ASKR, Phaneuf D, Neu HC: The effect of exchange transfusion on the blood levels of ampicillin and gentamycin in neonates. Infection 9:2-6, 1981
48. Ouellette SM, Visconti JA, Kennedy MS: A pharmacokinetic evaluation of the effect of plasma exchange on tobramycin disposition. Clin Exp Dial Apheresis 7:225-233, 1983
49. Kale-Pradhan PB, Dehoorne-Smith ML, Jaworski DA, Hare BL, Provenzano R, Higgins MJ: Evaluation of plasmapheresis on the removal of tobramycin. Pharmacotherapy 15:673-676, 1995
50. Nasca TJ, Huff N, Livengood BH: Phenytoin pharmacokinetics in therapeutic plasmapheresis. J Clin Pharmacol 25:302-304, 1985
51. Olsen KM, Marx MA, Monaghan MS, Barnes E, Ackerman BH, Pappas AA: Phenytoin and plasmapheresis: importance of sampling times and impact of obesity. Ther Drug Monit 16:624-628, 1994
52. Kale PB, Thomson PA, Provenzano R, Higgins MJ: Evaluation of plasmapheresis in the treatment of an acute overdose of carbamazepine. Ann Pharmacother 27:866-870, 1993
53. Chu G, Mantin R, Shen YM, Baskett G, Sussman H: Massive cisplatin overdose by accidental substitution for carboplatin. Toxicity and management. Cancer 72:3707-3714, 1993
54. Hofmann G, Bauernhofer T, Krippl P, Lang-Loidolt D, Horn S, Goessler W, Schippinger W, Ploner F, Stoeger H, Samonigg H: Plasmapheresis reverses all side-effects of a cisplatin overdose-a case report and treatment recommendation. BMC Cancer 6:1, 2006
55. Jung HK, Lee J, Lee SN: A case of massive cisplatin overdose managed by plasmapheresis. Korean J Intern Med 10:150-154, 1995
56. Tsang RY, Al-Fayea T, Au HJ: Cisplatin overdose: toxicities and management. Drug Saf 32:1109-1122, 2009
57. Samtleben W, Mistry-Burchardi N, Hartmann B, Lennertz A, Bosch T: Therapeutic plasma exchange in the intensive care setting. Ther Apher 5:351-357, 2001
58. Cecyn KZ, Lee J, Oguro T, Petrilli AS, Bordin JO: Use of plasma exchange in methotrexate removal in a patient with osteosarcoma and acute renal insufficiency. Am J Hematol 72:209-211, 2003
59. Kosmidis HV, Bouhoutsou DO, Varvoutsi MC, Papadatos J, Stefanidis CG, Vlachos P, Scardoutsou A, Kostakis A: Vincristine overdose: experience with 3 patients. Pediatr Hematol Oncol 8:171-178, 1991
60. Pierga JY, Beuzeboc P, Dorval T, Palangie T, Pouillart P: Favourable outcome after plasmapheresis for vincristine overdose. Lancet 340:185, 1992
61. Gutschmidt HJ: Successful plasmapheresis in severe diltiazem poisoning. Dtsch Med Wochenschr 120:81-82, 1995
62. Kuhlmann U, Schoenemann H, Muller T, Keuchel M, Lange H: Plasmapheresis in life- threatening verapamil intoxication. Artif Cells Blood Substit Immobil Biotechnol 28:429-440, 2000
63. Kuhlmann U, Schoenemann H, Muller TF, Keuchel M, Lange H: Plasmapheresis in fatal overdose with verapamil. Intensive Care Med 25:1473, 1999
64. Siebenlist D: Plasma separation in verapamil poisoning. Dtsch Med Wochenschr 115:797, 1990
65. Talbert RL, Wong YY, Duncan DB: Propranolol plasma concentrations and plasmapheresis. Drug Intell Clin Pharm 15:993-996, 1981
66. Berlin G, Brodin B, Hilden JO, Martensson J: Acute dapsone intoxication: a case treated with continuous infusion of methylene blue, forced diuresis and plasma exchange. J Toxicol Clin Toxicol 22:537-548, 1984
67. Turkcuer I, Erdur B, Sari I, Yuksel A, Tura P, Yuksel S: Severe metformin intoxication treated with prolonged haemodialyses and plasma exchange. Eur J Emerg Med 16:11-13, 2009
68. Kessler Jr DL, Smith AL, Woodrum DE: Chloramphenicol toxicity in a neonate treated with exchange transfusion. J Pediatr 96:140-141, 1980
69. Duzova A, Baskin E, Usta Y, Ozen S: Carbamazepine poisoning: treatment with plasma exchange. Hum Exp Toxicol 20:175-177, 2001
70. Gambi D, Oggioni R, Mangani V, Librenti M, Manescalchi F, Tulli G: Acute carbamazepine poisoning treated with plasmapheresis. Description of a clinical case. Minerva Anestesiol 59:547-552, 1993
71. Assael BM, Caccamo ML, Gerna M, Latini R, Mandelli M, Marini A, Sereni F, Tognoni G: Effect of exchange transfusion on elimination of theophylline in premature neonates. J Pediatr 91:331-332, 1977
72. Laussen P, Shann F, Butt W, Tibballs J: Use of plasmapheresis in acute theophylline toxicity. Crit Care Med 19:288-290, 1991
73. Foral MA, Heineman SM: Vancomycin removal during a plasma exchange transfusion. Ann Pharmacother 35:1400-1402, 2001
74. Osman BA, Lew SQ: Vancomycin removal by plasmapheresis. Pharmacol Toxicol 81:245-246, 1997
75. Sirvent AE, Borras-Blasco J, Enriquez R, Navarro-Ruiz A, Amoros FA: Extracorporeal removal of vancomycin by plasmapheresis. Ann Pharmacother 40:2279-2280, 2006
76. Lai CW, Leppik IE, Jenkins DC, Sood P: Epilepsy, myasthenia gravis, and effect of plasmapheresis on antiepileptic drug concentrations. Arch Neurol 47:66-68, 1990
77. Larsen LS, Sterrett JR, Whitehead B, Marcus SM: Adjunctive therapy of phenytoin overdose-a case report using plasmaphoresis. J Toxicol Clin Toxicol 24:37-49, 1986
78. Liu E, Rubenstein M: Phenytoin removal by plasmapheresis in thrombotic thrombocytopenic purpura. Clin Pharmacol Ther 31:762-765, 1982
79. Silberstein LE, Shaw LM: Effect of plasma exchange on phenytoin plasma concentration. Ther Drug Monit 8:172-176, 1986
80. Tobias JD, Baker DK, Hurwitz CA: Removal of phenytoin by plasmapheresis in a patient with thrombotic thrombocytopenia purpura. Clin Pediatr (Phila) 31:105-108, 1992
81. Kwon SU, Lim SH, Rhee I, Kim SW, Kim JK, Kim DW, Jeon ES: Successful whole blood exchange by apheresis in a patient with acute cyclosporine intoxication without long-term sequelae. J Heart Lung Transplant 25:483-485, 2006
82. Moorman MT, Epstein RB, Smith JW, O'Neal C, Holter JL: Management of cyclosporine overdose in a hematopoietic stem cell transplant patient with sequential plasma exchange and red blood cell exchange. J Clin Apher 26:156-158, 2011
83. Leitner GC, Hiesmayr M, Hoecker P, Jilma B: Therapeutic approaches in the management of oral cyclosporine A intoxication. Transplantation 75:1764-1765, 2003
84. White RL, Garnett WR, Allen JH, Kline BJ, Sharp DE: Phenytoin removal during plasma exchange. J Clin Apheresis 3:147-150, 1987
85. Henderson A, Hickman P, Ward G, Pond SM: Lack of efficacy of plasmapheresis in a patient overdosed with thyroxine. Anaesth Intensive Care 22:463-464, 1994
86. L'heureux PE, Lheureux OF, Penaloza-Baeza A: Metformin toxicity. Eur J Emerg Med 16:348-349, 2009
87. Unal S, Bayrakci B, Yasar U, Karagoz T: Successful treatment of propafenone, digoxin and warfarin overdosage with plasma exchange therapy and rifampicin. Clin Drug Investig 27:505-508, 2007
88. Chapman TM, Keating GM: Basiliximab: a review of its use as induction therapy in renal transplantation. Drugs 63:2803-2835, 2003
89. Okechukwu CN, Meier-Kriesche HU, Armstrong D, Campbell D, Gerbeau C, Kaplan B: Removal of basiliximab by plasmapheresis. Am J Kidney Dis 37:E11, 2001
90. Varl J, Ponikvar R, Drinovec J, Kveder R, Zemva Z: Effect of plasmapheresis on blood and plasma cyclosporin levels. Prog Clin Biol Res 337:363-365, 1990
91. Chan GL, Hodge EE: Effect of plasmapheresis on cyclosporine pharmacokinetics. DICP 25:211, 1991
92. Balogun RA, Sahadevan M, Sevigny J, Kaplan AA: Impact of therapeutic plasma exchange on cyclosporine kinetics during membrane-based lipid apheresis. Am J Kidney Dis 37:1286-1289, 2001
93. Novartis, Inc.: Mycophenolate Sodium (Myfortic) Prescribing Information. East Hanover, NJ: Novartis, Inc., 2009
94. Maldonado AQ, Davies NM, Crow SA, Little C, Ojogho ON, Weeks DL: Effects of plasmapheresis on mycophenolic acid concentrations. Transplantation 91:e3-e4, 2011
95. Biogen Idec, Inc.: Tysabri (Natalizumab) Prescribing Information. Cambridge, MA: Biogen Idec, Inc., 2011
96. Jacobson P, Uberti J, Davis W, Ratanatharathorn V: Tacrolimus: a new agent for the prevention of graft-versus-host disease in hematopoietic stem cell transplantation. Bone Marrow Transplant 22:217-225, 1998
97. Przepiorka D, Suzuki J, Ippoliti C, Hester JP, Fritsche HA: Blood tacrolimus concentration unchanged by plasmapheresis. Am J Hosp Pharm 51:1708, 1994
98. Hale GA, Reece DE, Munn RK, Kniska AB, Phillips GL: Blood tacrolimus concentrations in bone marrow transplant patients undergoing plasmapheresis. Bone Marrow Transplant 25:449-451, 2000
99. Bedford, Inc.: Methotrexate for Injection Prescribing Information. Bedford, OH: Bedford, Inc., 2005
100. Genentech, Inc.: Rituximab Prescribing Information. South San Francisco, CA: Genentech, Inc., 2011
101. Donigian DW, Owellen RJ: Interaction of vinblastine, vincristine and colchicine with serum proteins. Biochem Pharmacol 22:2113-2119, 1973
102. Roden DM: Pharmacokinetics of amiodarone: implications for drug therapy. Am J Cardiol 72:45F-50F, 1993
103. Meredith PA, Elliott HL: Clinical pharmacokinetics of amlodipine. Clin Pharmacokinet 22:22-31, 1992
104. Coltart DJ, Watson D, Howard MR: Effect of exchange transfusions on plasma digoxin levels. Arch Dis Child 47:814-815, 1972
105. Rosegger H, Zach M, Gleispach H, Beitzke A: Digoxin elimination by exchange transfusion. Eur J Pediatr 124:217-222, 1977
106. Rabetoy GM, Price CA, Findlay JW, Sailstad JM: Treatment of digoxin intoxication in a renal failure patient with digoxin-specific antibody fragments and plasmapheresis. Am J Nephrol 10:518-521, 1990
107. Ochs HR, Knuchel M: Pharmacokinetics and absolute bioavailability of diltiazem in humans. Klin Wochenschr 62:303-306, 1984
108. Evers J, Messer W, Aboudan F, Finke K: Mexiletine in terminal renal failure and various dialysis procedures. Klin Wochenschr 67:995-998, 1989
109. Pfizer, Inc.: Fragmin (Dalterparin) Prescribing Information. New York, NY: Pfizer, Inc., 2007
110. Berlex, Inc.: Refludan (Lepirudin (rDNA) for Injection) Prescribing Information. Montville, NJ: Berlex, Inc., 2004
111. Willey ML, de Denus S, Spinler SA: Removal of lepirudin, a recombinant hirudin, by hemodialysis, hemofiltration, or plasmapheresis. Pharmacotherapy 22:492-499, 2002
112. Chavanet PY, Bailly F, Mousson C, Waldner-Combernoux A, Lokiec F, Rebibou JM, Chalopin JM, Portier H: Acyclovir pharmacokinetics in plasmapheresis. J Clin Apheresis 5:68-69, 1990
113. Tan JA, Bannister T, Phair JP: Levels of amoxicillin and ampicillin in human serum and interstitial fluid. J Infect Dis 129(Suppl.):S146-S148, 1974
114. Blum RA, Kohli RK, Harrison NJ, Schentag JJ: Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis. Antimicrob Agents Chemother 33:1470-1476, 1989
115. Bakken JS, Cavalieri SJ, Gangeness D: Influence of plasma exchange pheresis on plasma elimination of ceftriaxone. Antimicrob Agents Chemother 34:1276-1277, 1990
116. Ambrose PJ: Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate. Clin Pharmacokinet 9:222-238, 1984
117. Barclay JA, Ziemba S, Ibrahim RB: Dapsone-induced methemoglobinemia: a primer for clinicians. Ann Pharmacother 45(9): 1103-1015, 2011.
118. Ronchera-Oms CL, Tormo C, Ordovas JP, Abad J, Jimenez NV: Expanded gentamicin volume of distribution in critically ill adult patients receiving total parenteral nutrition. J Clin Pharm Ther 20:253-258, 1995
119. Fuquay D, Koup J, Epstein MF, Smith AL: Effect of exchange transfusion on serum gentamicin concentrations. Dev Pharmacol Ther 3:214-221, 1981
120. Appelgate R, Schwartz D, Bennett WM: Removal of tobramycin during plasma exchange therapy. Ann Intern Med 94:820-821, 1981
121. Brophy DF, Mueller BA: Vancomycin removal by plasmapheresis. Ann Pharmacother 30:1038, 1996
122. Fauvelle F, Leon A, Petitjean O, Guillevin L: Zidovudine removal during plasma exchange. J Clin Apheresis 6:155-157, 1991
123. Christensen J, Balslev T, Villadsen J, Heinsvig EM, Dam M, Poulsen JH: Removal of 10- hydroxycarbazepine by plasmapheresis. Ther Drug Monit 23:374-379, 2001
124. Nelson E, Powell JR, Conrad K, Likes K, Byers J, Baker S, Perrier D: Phenobarbital pharmacokinetics and bioavailability in adults. J Clin Pharmacol 22:141-148, 1982
125. Bryson SM, Verma N, Scott PJ, Rubin PC: Pharmacokinetics of valproic acid in young and elderly subjects. Br J Clin Pharmacol 16:104-105, 1983
126. Robert F, Fendri S, Hary L, Lacroix C, Andrejak M, Lalau JD: Kinetics of plasma and erythrocyte metformin after acute administration in healthy subjects. Diabetes Metab 29:279-283, 2003
127. Pearson RM: Pharmacokinetics of propoxyphene. Hum Toxicol 3(Suppl.):37S-40S, 1984
128. Thamdrup B, Ostergaard OV, Clausen E: Plasma exchange in the treatment of propoxyphene intoxications. Int J Clin Pharmacol Ther Toxicol 24:379-380, 1986
129. Supanaranond W, Davis TM, Pukrittayakamee S, et al.: Disposition of oral quinine in acute falciparum malaria. Eur J Clin Pharmacol 40:49-52, 1991
130. Sabto JK, Pierce RM, West RH, Gurr FW: Hemodialysis, peritoneal dialysis, plasmapheresis and forced diuresis for the treatment of quinine overdose. Clin Nephrol 16:264-268, 1981
131. Zarowitz BJ, Peterson E, Popovich Jr J: Relationship of bioelectrical impedance to pharmacokinetic parameters of theophylline in healthy males. Clin Pharmacokinet 17:200-207, 1989
132. May ME, Mintz PD, Lowry P, Geller R, Curnow RT: Plasmapheresis in thyroxine overdose: a case report. J Toxicol Clin Toxicol 20:517-520, 1983
133. Liel Y, Weksler N: Plasmapheresis rapidly eliminates thyroid hormones from the circulation, but does not affect the speed of TSH recovery following prolonged suppression. Horm Res 60:252-254, 2003